Log In
BCIQ
Print this Print this
 

LY2606368

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionCheckpoint kinase 1 (Chk1; CHEK1) inhibitor
Molecular Target Checkpoint kinase 1 (Chk1) (CHEK1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today